New Zealand - English - Medsafe (Medicines Safety Authority)

new zealand diagnostics ltd - anti-beta hcg monoclonal antibody - pregnancy test kit - active: anti-beta hcg monoclonal antibody

New Zealand - English - Medsafe (Medicines Safety Authority)

wilson foods limited - anti-beta hcg monoclonal antibody - pregnancy test kit - active: anti-beta hcg monoclonal antibody

New Zealand - English - Medsafe (Medicines Safety Authority)

wilson foods limited - anti-beta hcg monoclonal antibody - pregnancy test kit - active: anti-beta hcg monoclonal antibody

New Zealand - English - Medsafe (Medicines Safety Authority)

wilson foods limited - murine monoclonal antibody to hcg - pregnancy test kit - 3.75mg/0.75mg - active: murine monoclonal antibody to hcg

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - anti-beta hcg monoclonal antibody - pregnancy test kit - active: anti-beta hcg monoclonal antibody

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - anti-alpha hcg monoclonal antibody - pregnancy test kit - active: anti-alpha hcg monoclonal antibody

European Union - English - EMA (European Medicines Agency)

roche registration gmbh  - pertuzumab - breast neoplasms - antineoplastic agents, monoclonal antibodies - metastatic breast cancer:perjeta is indicated for use in combination with trastuzumab and docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.neoadjuvant treatment of breast cancer:perjeta is indicated for use in combination with trastuzumab and chemotherapy for the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrence.

European Union - English - EMA (European Medicines Agency)

merck europe b.v. - avelumab - neuroendocrine tumors - other antineoplastic agents, monoclonal antibodies - bavencio is indicated as monotherapy for the treatment of adult patients with metastatic merkel cell carcinoma (mcc).bavencio in combination with axitinib is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (rcc).bavencio is indicated as monotherapy for the first‑line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc) who are progression-free following platinum‑based chemotherapy.

Singapore - English - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the tdx/tdxflx cyclosporine monoclonal whole blood assay is an in vitro reagent system for the quantitative measurement of cyclosporine (sandimmune®, cyclosporin a) in human whole blood as an aid in the management of cardiac, liver and renal transplant patients.

Singapore - English - HSA (Health Sciences Authority)

ortho-clinical diagnostics singapore pte. ltd. - hematology - for in vitro diagnostic use only. for direct agglutination test by column agglutination technology. the anti-k reagent is for the qualitative in vitro detection of human k positive red blood cells by the direct agglutination test.